Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Sjöwall

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
International Journal of Molecular Sciences|September 28, 2024
Immune Mechanisms and Biomarkers in Systemic Lupus ErythematosusIoannis Parodis, Christopher Sjöwall
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2007
Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteinsChristopher Sjöwall, Jonas Wetterö
Journal of Clinical Medicine|November 26, 2022
Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus ErythematosusChristopher Sjöwall, Ioannis Parodis
Frontiers in Pharmacology|February 22, 2019
Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus ErythematosusPer Eriksson, Philip Wallin, Christopher Sjöwall
Frontiers in Medicine|September 16, 2022
B cells in systemic lupus erythematosus: Targets of new therapies and surveillance toolsIoannis Parodis, Mariele Gatto, Christopher Sjöwall
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 24, 2015
Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?Helena Enocsson, Christopher Sjöwall, Jonas Wetterö
Frontiers in Medicine|August 6, 2020
B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical PracticeIoannis Parodis, Marit Stockfelt, Christopher Sjöwall
Rheumatology International|March 7, 2024
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional studyAlvaro Gomez, Ioannis Parodis, Christopher Sjöwall
Journal of Autoimmunity|November 7, 2002
Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel diseaseChristopher Sjöwall, Per Eriksson, Sven Almer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 2008
Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndromeJonas Wetterö, Lennart Nilsson, Lena Jonasson, et al.
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|September 28, 2024
Immune Mechanisms and Biomarkers in Systemic Lupus ErythematosusIoannis Parodis, Christopher Sjöwall
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2007
Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteinsChristopher Sjöwall, Jonas Wetterö
Journal of Clinical Medicine|November 26, 2022
Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus ErythematosusChristopher Sjöwall, Ioannis Parodis
Frontiers in Pharmacology|February 22, 2019
Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus ErythematosusPer Eriksson, Philip Wallin, Christopher Sjöwall
Frontiers in Medicine|September 16, 2022
B cells in systemic lupus erythematosus: Targets of new therapies and surveillance toolsIoannis Parodis, Mariele Gatto, Christopher Sjöwall
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 24, 2015
Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?Helena Enocsson, Christopher Sjöwall, Jonas Wetterö
Frontiers in Medicine|August 6, 2020
B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical PracticeIoannis Parodis, Marit Stockfelt, Christopher Sjöwall
Rheumatology International|March 7, 2024
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional studyAlvaro Gomez, Ioannis Parodis, Christopher Sjöwall
Journal of Autoimmunity|November 7, 2002
Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel diseaseChristopher Sjöwall, Per Eriksson, Sven Almer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 2008
Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndromeJonas Wetterö, Lennart Nilsson, Lena Jonasson, et al.
Pageof 17